Treatment of candidemia in adult patients without neutropenia - an inconvenient truth
Open Access
- 1 January 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 15 (1), 114
- https://doi.org/10.1186/cc9414
Abstract
In 2009 the Infectious Diseases Society of America reviewed the guidelines on the treatment of candidemia in non-neutropenic patients. In this document the preferred treatment was either fluconazole or an echinocandin. Amphotericin-B formulations were considered an alternative. However, careful assessment of published data showed similar efficacy between these drugs.Keywords
This publication has 15 references indexed in Scilit:
- Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Antifungal treatment for invasive Candida infections: a mixed treatment comparison meta-analysisAnnals of Clinical Microbiology and Antimicrobials, 2009
- Treatment of Invasive Candidal Infections: Systematic Review and Meta-analysisMayo Clinic Proceedings, 2008
- Anidulafungin versus Fluconazole for Invasive CandidiasisThe New England Journal of Medicine, 2007
- Echinocandins — First-Choice or First-Line Therapy for Invasive Candidiasis?The New England Journal of Medicine, 2007
- Making Sense of Noninferiority: A Clinical and Statistical Perspective on Its Application to Cardiovascular Clinical TrialsProgress in Cardiovascular Diseases, 2007
- Echinocandins for Candidemia in Adults without NeutropeniaThe New England Journal of Medicine, 2006
- Lessons From and Cautions About Noninferiority and Equivalence Randomized TrialsJAMA, 2006
- Guidelines for Treatment of CandidiasisClinical Infectious Diseases, 2004
- Amphotericin B nephrotoxicityJournal of Antimicrobial Chemotherapy, 2002